Replay available

The Ensign Group, Inc. (ENSG) Q4 2025 Earnings Call

The Ensign Group, Inc. (NASDAQ: ENSG) Q4 2025 earnings conference call, held 2026-02-05. Replay captured from the company's public earnings webcast.

Thu, February 5, 2026 at 1:00 PMendedReplay
The Ensign Group, Inc. (ENSG) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Clark Murphy

Analyst, Truist Securities

Raj Kumar

Analyst, Stevens

Ben Hendricks

Analyst, RBC Capital Markets

Chad Keech

Head of Investor Relations

Barry Porter

Chief Executive Officer

Replay transcript excerpt

Ladies and gentlemen, thank you for joining us and welcome to the Enzyme Group, Inc. fourth quarter fiscal year 2025 earnings conference call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please raise your hand. If you have dialed into today's call, please press star nine to raise your hand and star six to unmute. I will now hand the conference over to Mr. Keech. Please go ahead. Thank you, operator, and welcome, everyone. We filed our earnings press release yesterday, and it is available on the investor relations section of our website at anzinegroup.net. A replay of this call will also be available on our website until 5 p.m. Pacific on February 27, 2026. We want to remind anyone that might be listening to a replay of this call that all the statements made are as of today, February 5, 2026, and these statements have not been or will be updated subsequent to today's call. Also, any forward-looking statements made today are based on management's current expectations, assumptions, and beliefs about our business and the environment in which we operate. These statements are subject to the risks and uncertainties that could cause our actual results to materially differ from those expressed or implied on today's call. Listeners should not place under-reliance on forward-looking statements and are encouraged to review the SEC filings for a more complete discussion of factors that could impact our results. Except as required by federal securities laws, Enzyme and its independent subsidiaries do not undertake to publicly update or revise any forward-looking statements where changes arise as a result of new information, future events, changing circumstances, or for any other reason. In addition, the Enzyme Gr...

More from The Ensign Group, Inc.